Differential effects of agraz (vaccinium meridionale swartz) consumption in overweight and obese women with metabolic syndrome
ABSTRACT: Obesity implies higher cardiovascular risk (CVR) than overweight. Polyphenol-rich fruits have shown to ameliorate CVR factors (CVRF). It is not clear whether differential effects could be observed between obese and overweight people consuming these fruits. Objective: To evaluate the effect...
- Autores:
-
Marín Echeverri, Catalina
Piedrahita Blandón, Manuela
Galvis Pérez, Yeisson Anibal
Núñez Rangel, Vitelbina
Barona Acevedo, María Jacqueline
Fernández, María Luz
Blesso, Christopher N.
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/41069
- Acceso en línea:
- https://hdl.handle.net/10495/41069
- Palabra clave:
- Obesidad
Obesity
Estrés Oxidativo
Oxidative Stress
Inflamación
Inflammation
Factores de Riesgo de Enfermedad Cardiaca
Heart Disease Risk Factors
Antioxidantes
Antioxidants
https://id.nlm.nih.gov/mesh/D009765
https://id.nlm.nih.gov/mesh/D018384
https://id.nlm.nih.gov/mesh/D007249
https://id.nlm.nih.gov/mesh/D000082742
https://id.nlm.nih.gov/mesh/D000975
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by/2.5/co/
| Summary: | ABSTRACT: Obesity implies higher cardiovascular risk (CVR) than overweight. Polyphenol-rich fruits have shown to ameliorate CVR factors (CVRF). It is not clear whether differential effects could be observed between obese and overweight people consuming these fruits. Objective: To evaluate the effects of agraz on CVRF in overweight and obese women with metabolic syndrome (MetS). Methods: Overweight (n=22) and obese (n=18) women (25-60 years) with MetS, were included in this crossover, double-blind and placebo-controlled study. They consumed agraz or placebo over 4-weeks separated by a 4-wk washout period. At the end of each period, the following parameters were measured: anthropometrics, blood pressure, serum lipid profile, glucose, insulin, adipokines, apolipoprotein (apo)-A1, high sensitivity C-reactive protein (hs-CRP), serum total antioxidant capacity (TAC), endogenous antioxidant enzymes and oxidative stress (OxS) markers. Results: Compared to placebo, agraz consumption significantly (p<0.05) reduced hs-CRP and urinary 8-hydroxy 2 deoxyguanosine (8-OHdG) levels in overweight and obese women, respectively. In both groups, changes in antioxidant markers were significant (p<0.05) and negatively correlated with changes in CVR factors and OxS markers, respectively. Positive correlations were observed with cardioprotective markers. Conclusions: Agraz consumption had differential effects in overweight and obese women, with better effects on inflammation and OxS markers, respectively. Further studies should consider these differential responses when analyzing the results of an intervention, and eventually adjust to get better outcomes. |
|---|
